Compare · AHCO vs HIMS
AHCO vs HIMS
Side-by-side comparison of AdaptHealth Corp. (AHCO) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AHCO and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.29B, about 4.8x AHCO ($1.31B).
- Over the past year, AHCO is up 9.9% and HIMS is down 51.2% - AHCO leads by 61.1 points.
- HIMS has been more active in the news (20 items in the past 4 weeks vs 3 for AHCO).
- HIMS has more recent analyst coverage (25 ratings vs 12 for AHCO).
- Company
- AdaptHealth Corp.
- Hims & Hers Health Inc.
- Price
- $9.70+0.47%
- $27.79+2.24%
- Market cap
- $1.31B
- $6.29B
- 1M return
- -14.28%
- -1.94%
- 1Y return
- +9.92%
- -51.17%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- 2019
- News (4w)
- 3
- 20
- Recent ratings
- 12
- 25
AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest AHCO
- Chief Commercial Officer Schuster Iii Russell E. sold $113,426 worth of shares (11,275 units at $10.06) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 136,538 units (SEC Form 4)
- Amendment: AdaptHealth Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Chief Operating Officer Mcfadden Daniel Edward was granted 20,134 shares, increasing direct ownership by 24% to 103,376 units (SEC Form 4)
- SEC Form 10-Q filed by AdaptHealth Corp.
- AdaptHealth Corp. to Participate in Upcoming Investor Conferences
- AdaptHealth Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits
- AdaptHealth Corp. Announces First Quarter 2026 Results
- Amendment: Chief Technology Officer Prast Albert A. covered exercise/tax liability with 58,203 shares, decreasing direct ownership by 15% to 338,712 units (SEC Form 4)
- SEC Form DEF 14A filed by AdaptHealth Corp.
- AdaptHealth Corp. Announces First Quarter 2026 Earnings Release Date and Conference Call
Latest HIMS
- Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
- Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
- Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health Platform
- Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
- Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
- Director Wells David B bought $1,172,974 worth of shares (48,400 units at $24.23), increasing direct ownership by 27% to 224,417 units (SEC Form 4)
- SEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison